Innovate UK Biomedical Catalyst

MODERATE Tx General

Strategy Notes

The programme supports innovative UK businesses developing health solutions, which aligns with the venture's AI/biotech drug resistance prediction. However, the venture is not yet incorporated and targets EU/France, so UK eligibility may require establishing a UK entity.

Key Materials

—

Your Notes

Status & Deadline

Status: INELIGIBLE
Deadline: rolling
Cycle: rolling
Amount: up to £2.5M
Type: grant
URL: Apply

Update Status

Log Application

AI Pipeline

Research Programme Generate Draft

Status History

2026-07-31 OPEN → INELIGIBLE · The Innovate UK Biomedical Catalyst requires the applicant to be a UK-based business. Eniola Ayodele Olutogun is an independent researcher based in Nigeria/Germany with no UK entity, and the venture is not yet incorporated.